The reasons why the attainable serum concentration is the principal criterium for standardising Neo-Sensitabs are given, and at the same time details are shown of the interpretation of inhibition-zone readings. The elaborate co-operation between production department and control laboratory in the manufacturing process is described, and subsequently results from stability checks, performed by a microbiological method and by a chemical extraction method, are presented.